menu
    • menu

    Company profile for Arbele

    NEW Drugs in Dev: 3
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Arbele is a biotech and biopharmaceutical company that has created proprietary discovery platforms to accelerate the development of multifunctional “first-in-class” immunotherapeutics. It's goal is to rapidly generate more effective, ‘combination' treatments for gastrointestinal cancers, including stomach, pancreas, colon, bile duct and liver, which are currently high mortality cancers with limited treatment options.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ArbeleHongKong Flag
    Country
    Country
    Hong Kong
    Address
    Address
    Unit 522, Biotech Center 2, 11 Science Park West Ave., Shatin, N.T.
    Telephone
    Telephone
    (852) 3620 3002
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.arbelebio.com/eng/home
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    International Sweetener Colloquium

    Not Confirmed

    envelop Contact Supplier

    International Sweetener Colloquium

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Arbele Receives FDA Orphan Drug Designation for ARB1002
    Arbele Receives FDA Orphan Drug Designation for ARB1002

    07 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/arbele-receives-fda-orphan-drug-designation-for-arb1002-an-anti-cdh17-antibodydrug-conjugate-for-the-treatment-of-pancreatic-cancer-302654913.html

    PR NEWSWIRE
    07 Jan 2026
    Share Share
    Arbele Clinches Top Spot at BCIC's Biomedical Pitch Competition
    Arbele Clinches Top Spot at BCIC's Biomedical Pitch Competition

    02 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/arbele-wins-top-prize-at-bcics-4th-annual-biomedical-pitch-competition-302496632.html

    PR NEWSWIRE
    02 Jul 2025
    Share Share
    Arbele Enters AI Alliances in Precision Oncology and Manufacturing
    Arbele Enters AI Alliances in Precision Oncology and Manufacturing

    10 Oct 2024

    // CONTRACTPHARMA

    https://www.contractpharma.com//contents/view_breaking-news/2024-10-10/arbele-enters-strategic-ai-alliances-in-precision-oncology-and-manufacturing/?widget=listSection

    CONTRACTPHARMA
    10 Oct 2024
    Share Share
    Arbele Announces Collaborations On AI Precision Oncology Advances
    Arbele Announces Collaborations On AI Precision Oncology Advances

    09 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/arbele-announces-strategic-collaborations-on-ai-precision-oncology-and-manufacturing-to-advance-cdh17-targeted-immunotherapeutics-302271199.html

    PR NEWSWIRE
    09 Oct 2024
    Share Share
    T-Cell Engager ARB202 Explored in GI Cancers
    T-Cell Engager ARB202 Explored in GI Cancers

    26 Apr 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/novel-t-cell-engager-cdh17-x-cd3-cabotamig-arb202-continues-to-explore-dosing-in-patients-with-advanced-gastrointestinal-cancers-302128499.html

    PR NEWSWIRE
    26 Apr 2024
    Share Share
    Arbele announces safety data for novel CDH17xCD3 bispecific T-cell engager
    Arbele announces safety data for novel CDH17xCD3 bispecific T-cell engager

    02 Aug 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/arbele-announces-early-safety-data-for-novel-cdh17xcd3-bispecific-t-cell-engager-at-american-society-of-clinical-oncology-breakthrough-meeting-301891273.html

    PR NEWSWIRE
    02 Aug 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search